Skip to main content

Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from “neutral” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $56 to $69. Cubist's shares closed at $57.00 yesterday.

Analysts at Benchmark upgraded Open Text (NASDAQ: OTEX) from “hold” to “buy.” The target price for Open Text is set to $85. Open Text's shares closed at $67.46 yesterday.

Analysts at Piper Jaffray upgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from “neutral” to “overweight.” The target price for Questcor Pharmaceuticals has been raised from $41 to $74. Questcor's shares closed at $51.91 yesterday.

Analysts at JP Morgan upgraded Compass Minerals International (NYSE: CMP) from “underweight” to “neutral” The target price for Compass Minerals International has been raised from $65 to $66. Compass Minerals International's shares closed at $73.06 yesterday.

Latest Ratings for CBST

DateFirmActionFromTo
Dec 2014UBSDowngradesBuyNeutral
Dec 2014OppenheimerDowngradesOutperformMarket Perform
Dec 2014MizuhoDowngradesBuyNeutral

View More Analyst Ratings for CBST
View the Latest Analyst Ratings

 

Related Articles (CBST + OTEX)

View Comments and Join the Discussion!

Posted-In: top upgradesUpgrades Analyst Ratings

Latest Ratings

StockFirmActionPT
FSRMorgan StanleyMaintains40.0
NATJefferiesMaintains2.8
MEDDA DavidsonMaintains302.0
VICRBWS FinancialMaintains120.0
PSXMizuhoMaintains96.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com